On September 12, 2022, President Joseph R. Biden issued the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Economy. This Executive Order (E.O.) launches a National Biotechnology and Biomanufacturing Initiative to focus federal investments that transform biotechnology discoveries into solutions for critical problems.
The E.O. directs NIST, in partnership with federal and other stakeholders, to:
A "lexicon" provides a common language to help ensure clear communication among stakeholders referencing key aspects of the bioeconomy.
NIST will also play a role, along with other Department of Commerce bureaus, in contributing to a report assessing how biotechnology and biomanufacturing can be used to strengthen the resilience of United States supply chains, and helping to address challenges in biomanufacturing supply chains and related biotechnology development infrastructure in creating a vibrant, domestic biomanufacturing ecosystem.
Under Secretary of Commerce for Standards and Technology and NIST Director Laurie E. Locascio lauded the administration’s actions to support biomanufacturing and biotechnology, stating, “The National Institute of Standards and Technology is a leader in advancing measurement science, standards, data, and tools for emerging biotechnologies. This Executive Order emphasizes the importance of federal engagement with industry to achieve a strong and resilient domestic bioeconomy, and NIST’s critical role for the nation.”
NIST provides innovative solutions aligned with the goals of the National Biotechnology and Biomanufacturing Initiative through:
NIST will work with the Department of Commerce bureaus and other federal agencies to support the E.O.’s principles of focusing federal investments to transform biotechnology discoveries into tangible benefits, expand domestic biomanufacturing capacity, and maintain America’s competitive edge in biotechnology and biomanufacturing.